Oryzon Genomics S.A. (BME:ORY)
Spain
· Delayed Price · Currency is EUR 2.635
+0.050 (1.93%)
May 15, 2025, 4:39 PM CET
Oryzon Genomics Revenue
Oryzon Genomics had revenue of $7.95M USD in the twelve months ending March 31, 2025, down -48.05% year-over-year. In the year 2024, Oryzon Genomics had annual revenue of $7.62M, down -51.43%.
Revenue (ttm)
$7.95M
Revenue Growth
-48.05%
P/S Ratio
27.23
Revenue / Employee
$169.23K
Employees
47
Market Cap
200.37M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.62M | -8.07M | -51.43% |
| Dec 31, 2023 | 15.69M | -1.09M | -6.50% |
| Dec 31, 2022 | 16.78M | 4.70M | 38.97% |
| Dec 31, 2021 | 12.07M | 425.74K | 3.66% |
| Dec 31, 2020 | 11.65M | 112.98K | 0.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.21B |
| Laboratorios Farmaceuticos Rovi | 767.47M |
| Almirall | 1.03B |
| Pharma Mar | 175.75M |
| Faes Farma | 524.02M |
| Clínica Baviera | 265.72M |
| Laboratorio Reig Jofre | 338.90M |
| Atrys Health | 218.10M |
Oryzon Genomics News
- 3 days ago - Oryzon Genomics S.A. GAAP EPS of -$0.03 - Seeking Alpha
- 2 months ago - Oryzon Genomics S.A. GAAP EPS of -$0.02 - Seeking Alpha
- 3 months ago - ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders' Meeting - Benzinga